Adiponectin attenuates angiotensin II-induced oxidative stress in renal tubular cells through AMPK and cAMP-Epac signal transduction pathways
| Autor: | James W. Scholey, Joyce Zhou, Rana Yassa, Fei Fang, George C. Liu, Crystal Kim |
|---|---|
| Rok vydání: | 2013 |
| Předmět: |
medicine.medical_specialty
Physiology Adipokine Gene Expression AMP-Activated Protein Kinases medicine.disease_cause Kidney Tubules Proximal Renin-Angiotensin System Internal medicine medicine Cyclic AMP Guanine Nucleotide Exchange Factors Humans Drug Interactions Risk factor Enzyme Inhibitors Renal Insufficiency Chronic Cells Cultured Adiponectin business.industry Angiotensin II NF-kappa B AMPK NADPH Oxidases medicine.disease Fibronectins Enzyme Activation Oxidative Stress Endocrinology Pyrimidines Pyrazoles Signal transduction Receptors Adiponectin business hormones hormone substitutes and hormone antagonists Oxidative stress Kidney disease Signal Transduction |
| Zdroj: | American journal of physiology. Renal physiology. 304(11) |
| ISSN: | 1522-1466 |
| Popis: | Obesity is a risk factor for chronic kidney disease (CKD) progression. Circulating levels of adiponectin, an adipokine, decrease with obesity and play a protective role in the cardiovascular system. We hypothesized that adiponectin might also protect the kidney. Because activation of the renin-angiotensin system (RAS) is a contributor to CKD progression, we tested our hypothesis by studying the interactions between adiponectin and angiotensin II (ANG II) in renal tubular cells. Primary human renal proximal tubule cells expressed both adiponectin receptor 1 and 2 (adipoR1 and R2). ANG II-induced NADPH oxidase activation and oxidative stress were attenuated by adiponectin and dependent on adipoR1. Activation of AMPK with 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside (AICAR) mimicked, while inhibition of AMPK with compound C abrogated, the effect of adiponectin on ANG II-induced activation of NADPH oxidase. Similarly, the effect of adiponectin was recapitulated by the stable cAMP analogs 4-chlorophenylthio (pCPT)-cAMP and dibutyryl (db)-cAMP and blocked by the adenylate cyclase inhibitor SQ22536. Adiponectin did not activate PKA in renal tubular cells, and the specific PKA inhibitor myristoylated PKI (14–22) amide failed to block the inhibitory effect of adiponectin on ANG II-induced NADPH oxidase activation. In contrast, the specific Epac activator 8-(4-chlorophenylthio)-2′-O-methyl (8-CPT-2-O-Me)-cAMP blocked ANG II-induced activation of NADPH oxidase, an effect that was reversed by coincubation with the AMPK inhibitor compound C. Finally, adiponectin attenuated ANG II-induced NF-κB activation and fibronectin protein expression. These in vitro findings support the hypothesis that adiponectin may attenuate the deleterious effects of ANG II in the kidney and play a protective role in CKD. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|